United States · FDA National Drug Code directory
KESIMPTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed
- Product NDC
- 0078-1007
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ofatumumab
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20091026
- Source listing expiry
- 20271231
Source-listed ingredients
- OFATUMUMAB — 20 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS · 0078-1007-68
- 1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS · 0078-1007-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →